Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus responsible for coronavirus disease 2019 (COVID-19).1,2 The virus enters cells via the angiotensin-converting enzyme 2 receptor, which is present in enterocytes in the ileum and colon.3 Gastrointestinal (GI) manifestations include diarrhea, nausea, vomiting, and abdominal pain, and the prevalence of GI symptoms varies greatly, with a range between 2% and 57%.4 In addition, abnormal liver chemistries are reported commonly.4 As a medical center at the forefront of the early epidemic in the United States, we seek to contribute to the growing body of literature that outlines the gastrointestinal and hepatic manifestations of COVID-19.

中文翻译：

---

纽约州皇后区892名患者的SARS-CoV-2感染的胃肠道和肝脏表现分析。

严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）是一种导致2019年冠状病毒疾病（COVID-19）的RNA病毒.1,2该病毒通过血管紧张素转化酶2受体进入细胞，该受体存在于肠小肠上皮细胞中。 3胃肠道（GI）表现包括腹泻，恶心，呕吐和腹痛，且胃肠道症状的发生率差异很大，范围在2％至57％之间。4此外，据报道肝化学异常通常作为一个医疗中心，它是美国早期流行病的最前沿。我们力求为概述COVID-19的胃肠道和肝脏表现的文献不断发展做出贡献。